Found 224 matching trials
Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia PHASE2 Phase II study to evaluate safety and efficacy of DCP-001 in patients with ...
Show More Location
Helsinki University Hospital
Learn More & Join Trial
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT EARLY_PHASE1 The purpose of this study is to evaluate the efficacy and safety of allogen...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Study to Assess an Interphase Cycle With Flotetuzumab. PHASE2 Patients who have measurable residual disease (MRDpos, defined as MRD \> 0....
Show More Location
NL-Amsterdam-VUMC
Learn More & Join Trial
Natural Killer(NK) Cell Therapy in Acute Myeloid Leukemia PHASE1 This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS PHASE1 This is a first-in-human dose escalation/dose expansion study to evaluate t...
Show More Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Monitoring Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic Leukemia N/A This study aimed to investigate the performance of next-generation sequenci...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial NA The goal of this interventional clinical trial is to compare the efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia PHASE2 This is a prospective, single-arm, exploratory study evaluating the combina...
Show More Location
Shenzhen University general hospital
Learn More & Join Trial
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC N/A Multi-center observational clinical study to evaluate the application value...
Show More Location
Parc de Salut Mar - Hospital del Mar
Learn More & Join Trial
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD PHASE2 The purpose of this research study is to see if people whose Acute myeloid ...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial